- Home
- DDD vs EBS Comparison
DDD vs EBS Comparison
Compare DDD & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDD
- EBS
- Stock Information
- Founded
- DDD 1986
- EBS 1998
- Country
- DDD United States
- EBS United States
- Employees
- DDD N/A
- EBS N/A
- Industry
- DDD Computer peripheral equipment
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- DDD Technology
- EBS Health Care
- Exchange
- DDD Nasdaq
- EBS Nasdaq
- Market Cap
- DDD 328.3M
- EBS 359.3M
- IPO Year
- DDD N/A
- EBS 2006
- Fundamental
- Price
- DDD $2.28
- EBS $7.79
- Analyst Decision
- DDD Buy
- EBS Strong Buy
- Analyst Count
- DDD 2
- EBS 3
- Target Price
- DDD $5.00
- EBS $14.33
- AVG Volume (30 Days)
- DDD 3.7M
- EBS 955.8K
- Earning Date
- DDD 08-11-2025
- EBS 11-05-2025
- Dividend Yield
- DDD N/A
- EBS N/A
- EPS Growth
- DDD N/A
- EBS N/A
- EPS
- DDD N/A
- EBS 2.53
- Revenue
- DDD $413,342,000.00
- EBS $851,600,000.00
- Revenue This Year
- DDD N/A
- EBS N/A
- Revenue Next Year
- DDD $1.78
- EBS $19.24
- P/E Ratio
- DDD N/A
- EBS $3.09
- Revenue Growth
- DDD N/A
- EBS N/A
- 52 Week Low
- DDD $1.32
- EBS $4.02
- 52 Week High
- DDD $5.00
- EBS $12.73
- Technical
- Relative Strength Index (RSI)
- DDD 56.18
- EBS 45.67
- Support Level
- DDD $2.08
- EBS $7.45
- Resistance Level
- DDD $2.36
- EBS $8.62
- Average True Range (ATR)
- DDD 0.14
- EBS 0.38
- MACD
- DDD -0.00
- EBS -0.09
- Stochastic Oscillator
- DDD 45.75
- EBS 26.80
About DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.